Latest & greatest articles for fibromyalgia

The Trip Database is a leading resource to help health professionals find trustworthy answers to their clinical questions. Users can access the latest research evidence and guidance to answer their clinical questions. We have a large collection of systematic reviews, clinical guidelines, regulatory guidance, clinical trials and many other forms of evidence. If you wanted the latest trusted evidence on fibromyalgia or other clinical topics then use Trip today.

This page lists the very latest high quality evidence on fibromyalgia and also the most popular articles. Popularity measured by the number of times the articles have been clicked on by fellow users in the last twelve months.

What is Trip?

Trip is a clinical search engine designed to allow users to quickly and easily find and use high-quality research evidence to support their practice and/or care.

Trip has been online since 1997 and in that time has developed into the internet’s premier source of evidence-based content. Our motto is ‘Find evidence fast’ and this is something we aim to deliver for every single search.

As well as research evidence we also allow clinicians to search across other content types including images, videos, patient information leaflets, educational courses and news.

For further information on Trip click on any of the questions/sections on the left-hand side of this page. But if you still have questions please contact us via jon.brassey@tripdatabase.com

Top results for fibromyalgia

101. Telephone- and internet-based cognitive behavioral therapies for fibromyalgia

Telephone- and internet-based cognitive behavioral therapies for fibromyalgia Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. CRD bears no responsibility or liability for the content of this registration record, any associated files or external websites. Email salutation (e.g. "Dr Smith" or "Joanne") for correspondence: Organisation web address: Timing and effect

2017 PROSPERO

102. Impact of therapeutic interventions on endogenous pain modulation and pain intensity in fibromyalgia: a meta-analysis

Impact of therapeutic interventions on endogenous pain modulation and pain intensity in fibromyalgia: a meta-analysis Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. CRD bears no responsibility or liability for the content of this registration record, any associated files or external websites. Email salutation (e.g. "Dr Smith" or "Joanne") for correspondence

2017 PROSPERO

103. Fibromyalgia and vitamin D: which came first? A systematic review

Fibromyalgia and vitamin D: which came first? A systematic review Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. CRD bears no responsibility or liability for the content of this registration record, any associated files or external websites. Email salutation (e.g. "Dr Smith" or "Joanne") for correspondence: Organisation web address: Timing and effect measures

2017 PROSPERO

104. Inflammatory markers in patients with fibromyalgia syndrome compared with healthy controls: a systematic review, meta-analysis and meta-regression

Inflammatory markers in patients with fibromyalgia syndrome compared with healthy controls: a systematic review, meta-analysis and meta-regression Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. CRD bears no responsibility or liability for the content of this registration record, any associated files or external websites. Email salutation (e.g. "Dr Smith

2017 PROSPERO

105. Mirtazapine for fibromyalgia in adults [Cochrane protocol]

Mirtazapine for fibromyalgia in adults [Cochrane protocol] Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. CRD bears no responsibility or liability for the content of this registration record, any associated files or external websites. Email salutation (e.g. "Dr Smith" or "Joanne") for correspondence: Organisation web address: Timing and effect measures Timing

2017 PROSPERO

106. The efficacy of low-level laser therapy on patients with fibromyalgia: a systematic review and meta-analysis

The efficacy of low-level laser therapy on patients with fibromyalgia: a systematic review and meta-analysis Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. CRD bears no responsibility or liability for the content of this registration record, any associated files or external websites. Email salutation (e.g. "Dr Smith" or "Joanne") for correspondence: Organisation

2017 PROSPERO

107. Prevalence of depression in fibromyalgia syndrome: a systematic review and meta-analysis

Prevalence of depression in fibromyalgia syndrome: a systematic review and meta-analysis Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. CRD bears no responsibility or liability for the content of this registration record, any associated files or external websites. Email salutation (e.g. "Dr Smith" or "Joanne") for correspondence: Organisation web address: Timing

2017 PROSPERO

108. Effectiveness and safety of tramadol in the treatment of patients with fibromyalgia: systematic review

Effectiveness and safety of tramadol in the treatment of patients with fibromyalgia: systematic review Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. CRD bears no responsibility or liability for the content of this registration record, any associated files or external websites. Email salutation (e.g. "Dr Smith" or "Joanne") for correspondence: Organisation web

2017 PROSPERO

109. Fibromyalgia syndrome is associated with negatively variable impacts on domains of female sexual function: evidence from a systematic review and meta-analysis

Fibromyalgia syndrome is associated with negatively variable impacts on domains of female sexual function: evidence from a systematic review and meta-analysis Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. CRD bears no responsibility or liability for the content of this registration record, any associated files or external websites. Email salutation (e.g. "Dr

2017 PROSPERO

111. Effect of physical exercise in patients with fibromyalgia syndrome: an umbrella review of high quality systematic reviews

Effect of physical exercise in patients with fibromyalgia syndrome: an umbrella review of high quality systematic reviews Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. CRD bears no responsibility or liability for the content of this registration record, any associated files or external websites. Email salutation (e.g. "Dr Smith" or "Joanne") for correspondence

2017 PROSPERO

112. A systematic review of the efficacy of psychological interventions to relieve depressive symptoms in people with fibromyalgia

A systematic review of the efficacy of psychological interventions to relieve depressive symptoms in people with fibromyalgia Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. CRD bears no responsibility or liability for the content of this registration record, any associated files or external websites. Email salutation (e.g. "Dr Smith" or "Joanne

2017 PROSPERO

113. Cannabis and cannabinoids for medical purposes: a systematic review for the treatment of fibromyalgia

Cannabis and cannabinoids for medical purposes: a systematic review for the treatment of fibromyalgia Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. CRD bears no responsibility or liability for the content of this registration record, any associated files or external websites. Email salutation (e.g. "Dr Smith" or "Joanne") for correspondence: Organisation web

2017 PROSPERO

114. Effects of physical exercises on inflammatory markers in patients with fibromyalgia syndrome: systematic review

Effects of physical exercises on inflammatory markers in patients with fibromyalgia syndrome: systematic review Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. CRD bears no responsibility or liability for the content of this registration record, any associated files or external websites. Email salutation (e.g. "Dr Smith" or "Joanne") for correspondence

2017 PROSPERO

115. Effect of electric stimulation on pain in subjects with fibromyalgia: a systematic review and meta-analysis of randomized controlled clinical trials

Effect of electric stimulation on pain in subjects with fibromyalgia: a systematic review and meta-analysis of randomized controlled clinical trials Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. CRD bears no responsibility or liability for the content of this registration record, any associated files or external websites. Email salutation (e.g. "Dr Smith

2017 PROSPERO

116. Is resistance exercise beneficial to improve function, mobility, and quality of life, in patients with fibromyalgia?

Is resistance exercise beneficial to improve function, mobility, and quality of life, in patients with fibromyalgia? Getting Evidence into Clinical Practice: Musculoskeletal Research Facilitation Group (CAT Group) Date: November 2017 CAT Lead: Laura Freeman/ Treena Larkin Date CAT completed: November 2017 Email: Treena.larkin@nhs.net Date to be reviewed: November 2021 Specific Question: Is resistance exercise beneficial to improve function, mobility, quality of life in adult patients (...) with fibromyalgia? Clinical bottom line There is low quality evidence to support that moderate and moderate to high intensity resistance exercise can be safely performed and is beneficial for women with fibromyalgia to help with pain, tenderness, strength and function. This evidence supports the use of exercise in the treatment of fibromyalgia and can help inform treatment decisions. However clinicians must remain mindful that this review was based on evidence deemed low quality and only involved women

2017 Public Health England

117. Does exercise improve symptoms in fibromyalgia? Full Text available with Trip Pro

Does exercise improve symptoms in fibromyalgia? It has been proposed that fibromyalgia could be managed by pharmacological and non-pharmacological interventions. Regular physical exercise is commonly used as a non-pharmacological intervention. Searching in Epistemonikos database, which is maintained by screening 30 databases, we identified 14 systematic reviews including 25 randomized trials. We combined the evidence using meta-analysis and generated a summary of findings table following (...) the GRADE approach. We conclude that regular physical exercise probably reduces pain in patients with fibromyalgia.

2016 Medwave

118. QT dispersion and P wave dispersion in patients with fibromyalgia Full Text available with Trip Pro

QT dispersion and P wave dispersion in patients with fibromyalgia Fibromyalgia (FM) is a chronic disease characterized by widespread pain. Somatic complaints associated with the cardiovascular system, such as chest pain and palpitations, are frequently seen in FM patients. P and QT dispersions are simple and inexpensive measurements reflecting the regional heterogeneity of atrial and ventricular repolarization, respectively. QT dispersion can cause serious ventricular arrhythmias. The aim (...) were shorter in the FM group compared with the HC group (p<0.001 for both). In terms of the P wave dispersion value, there was no significant difference between the FM and HC groups (p=0.088).Longer QT and P wave dispersions are not problems in patients with FM. Therefore, it may be concluded that fibromyalgia does not include an increased risk of atrial and/or ventricular arrhythmias.

2016 European journal of rheumatology

119. The association between borderline personality disorder, fibromyalgia and chronic fatigue syndrome: systematic review. Full Text available with Trip Pro

The association between borderline personality disorder, fibromyalgia and chronic fatigue syndrome: systematic review. Overlap of aetiological factors and demographic characteristics with clinical observations of comorbidity has been documented in fibromyalgia syndrome, chronic fatigue syndrome (CFS) and borderline personality disorder (BPD).The purpose of this study was to assess the association of BPD with fibromyalgia syndrome and CFS. The authors reviewed literature on the prevalence of BPD (...) in patients with fibromyalgia or CFS and vice versa.A search of five databases yielded six eligible studies. A hand search and contact with experts yielded two additional studies. We extracted information pertaining to study setting and design, demographic information, diagnostic criteria and prevalence.We did not identify any studies that specifically assessed the prevalence of fibromyalgia or CFS in patients with BPD. Three studies assessed the prevalence of BPD in fibromyalgia patients and reported

2016 BJPsych open

120. Determining the Minimal Clinically Important Difference for Six-Minute Walk Distance in Fibromyalgia Full Text available with Trip Pro

Determining the Minimal Clinically Important Difference for Six-Minute Walk Distance in Fibromyalgia The aim of this study was to estimate the minimal clinically important difference (MCID) for 6-min walk distance (6MWD) in patients with fibromyalgia.Data from a recently completed trial that included 187 patients who completed the 6-min walk test, Fibromyalgia Impact Questionnaire (FIQ), and Short-Form 36 (SF36) at 12 and 36 wks were used to examine longitudinal changes in 6MWD. An anchor-based (...) -point increase).The MCID for 6MWD in patients with fibromyalgia was 156 to 167 m. These findings provide the first evidence of the change in 6MWD that is perceived by patients to be clinically meaningful. Further research using other MCID calculation methods is needed to refine estimates of the MCID for 6MWD in patients with fibromyalgia.

2016 American journal of physical medicine & rehabilitation Controlled trial quality: uncertain